Social Language Learning Trends – 2022

May 16, 2022 by

Trends in Language & Social Learning during 2022

The way we communicate is changing faster than the speed of sound, it seems, especially with the globalization of commerce and international social media platforms that favor people who speak more than one language. The way we learn languages is also evolving rapidly, with the graphically-rich virtual space of the metaverse creating a comfortable and effective learning environment.

The demand for online learning has never been stronger, especially when it comes to learning a language online. In fact, global online language learning market size and share revenue was worth $14.2 billion in 2021, and many expect it to exceed $28.5 billion by 2028. As demand and usage grows this year, certain trends will undoubtedly emerge.

Artificial intelligence (AI)

Artificial Intelligence (AI) research and development continued at a blistering pace during the pandemic. AI molds the learning experience to the user, allowing learners to work at their own pace and in their own way. AI-powered platforms repeat topics and emphasize areas that are challenging to the user, appeals to their interests, engages them with tasks they are good at, and even adapts to the cultural background of the user.

AI and immersive technologies, such as Augmented Reality (AR), Virtual Reality (VR), Mixed Reality (MR) and Extended Reality (XR), will continue to be strong performers in 2022. AR adds to intriguing images and graphics to existing educational content, while VR bridges the gap between theory and real-world applications.

Bite-sized training

Getting too much information all at once can be mind-numbing experience. What’s more, people are busier than ever and simply do not have hours to spend each week learning a language. In fact, employees devote a mere 24 minutes to learning each week. Microlearning breaks down content into bite-sized pieces that take only 5 to 10 minutes to complete.

Mobile delivery

There are currently 6.648 billion smartphones in the world today, which means about 83.72 percent of the global population owns a smartphone. Clearly, mobility is an essential part of daily life. What’s more, smartphones are capable of doing much more than placing calls and sending texts – many of today’s smartphones rival the smartest laptops or tablets. In 2022, an increasing number of people are likely to use their smartphones to learn a language. 

Social language learning apps

The best way to learn a new language is to chat with real people around the world who speak the language every day, of course, but traveling to foreign lands simply to pick up a language is expensive and time-consuming. Social language learning apps allow users to enjoy all the benefits of immersion-based learning without ever leaving the comfort of their own home.

HeyPal™ will likely be a trend-setter for social language learning apps in 2022. As one of the fastest growing language learning apps, exceeding a million downloads in just months after its release, HeyPal is fun to use and easy to understand. This nifty app uses suggestive messaging that allow users to spark conversations and kickstart friendships with one single tap, which ultimately accelerates learning. The messaging system allows users to write direct message prompts for one-click sending, record a voice note and send the answer to a prompt, or even record a video to send. Algorithms allow users to build their social profiles to increase global followers, upload fun and engaging videos as a form of communication, and even communicate with native speakers in real-time or post on boards specific to different languages.

Premium memberships

People want more from their language and social learning apps, and are willing to purchase premium memberships to unlock the potential of their apps.

HeyPal™ offers a Premium Membership plan that makes it easier than ever to learn a new language through social learning. Their Premium Membership includes unlimited chats, translations, language feeds, influencer feeds and features, and group chats. It also provides access to the new PenPal matching feature, in which an advanced algorithm matches up HeyPal users with new users to help them learn and practice their language of choice. It also includes Suggestive Messaging, a predictive text feature, which allows learners to kick start conversations with a single tap.

The demand for online learning will continue to grow through 2022. Many of today’s trends will influence the growth and development of online language learning throughout the next century.

ABOUT FRANK MAGLIOCHETTI

Frank Magliochetti owes his professional success to his expertise in two areas: medicine and finance. After obtaining a BS in pharmacy from Northeastern University, he stayed on to enroll in the Masters of Toxicology program. He later specialized in corporate finance, receiving an MBA from The Sawyer School of Business at Suffolk University. His educational background includes completion of the Advanced Management Program at Harvard Business School and the General Management Program at Stanford Business School. Frank Magliochetti has held senior positions at Baxter International, Kontron Instruments, Haemonetics Corporation, and Sandoz. Since 2000, he has been a managing partner at Parcae Capital, where he focuses on financial restructuring and interim management services for companies in the healthcare, media, and alternative energy industries. Last year, he was appointed chairman of the board at Grace Health Technology, a company providing an enterprise solution for the laboratory environment.

Frank is the CEO of ClickStream, ClickStream’s business operations are focused on the development and implementation of apps that disrupt such as WinQuik™, a free to play synchronized mobile app and digital gaming platform. The platform is designed to enable WinQuik™ users to have fun, interact and compete against each other in order to win real money and prizes. Twitter at @ClickstreamC  @WinQuikApp, Nifter™, a music NFT marketplace that allows recording artists to create and sell limited edition authenticated NFTs, and their ever expanding foreign language exchange social learning app  @HeyPalApp. ClickStream is also entering the E-Learning market with Joey’s Animal Kingdom- please visit them online at wowee.world

Frank was appointed Chairman and Chief Executive Officer at Designer Genomics International, Inc. The Company has accumulated a growing body of evidence that highlights a link between alterations in the immune and inflammatory systems and the development of chronic human disease. The Company is visionary and has established itself as a leader in the field of inflammatory and immune genetic DNA and RNA biomarkers that play a causative role in debilitating conditions, such as atherosclerosis/heart disease, diabetes, arthritis, inflammatory bowel disease, post-traumatic stress disorders (PTSD) and cancer.
A proprietary state-of-the art data mining bioinformatics program, called ‘cluster analysis’ will be used to measure disease development susceptibility with potential for earlier diagnosis and intervention. The company is developing a healthcare program based on its proprietary genetic panels that will allow people to be their own healthcare advocate and take an active role in their health status as well as longevity.
Frank is a highly sought after multifaceted senior C level executive.

This image has an empty alt attribute; its file name is frankmagliochetti_FrankMagliochettiNews.jpg
Mr. Frank Magliochetti MBA
Managing Partner
Parcae Capital
www.parcaecapitalcorp.com
www.frankmagliochetti.com

SOURCES

https://sports.yahoo.com/demand-global-online-language-learning-160500001.html

https://www.bankmycell.com/blog/how-many-phones-are-in-the-world

Filed Under: App Development, ClickStream, Featured, Foreign Language App, Hey Pal, HeyPal App, Language Apps, News, Trends Tagged With: , , , , , , ,

ClickStream CEO Frank Magliochetti Talks about Disrupting Conventional Industries

November 25, 2021 by

CLICKSTREAM CEO FRANK MAGLIOCHETTI TALKS DISRUPTING CONVENTIONAL INDUSTRIES THROUGH APPS, EXPLODING NFT TECH, AND WHY CLIS IS A SMART INVESTMENT TODAY

In an incredibly thorough and and candid interview Hazel Saunders of the Ritz Herald talks with Frank M<agliochetti about all things ClickStream!

Here is the Interview: for the original source please head to The Ritz Herald.

There are no businesses with greater potential today than those positioned to dominate booming digital economies. One company that knows that more than anyone is ClickStream, a rapidly expanding business that is on a mission to disrupt conventional industries by way of game-changing mobile apps. ClickStream is traded on the stock market as CLIS.

These app subsidiaries span a multitude of industries: from gaming and language learning to investing early on tech which facilitates the exploding NFT industry. But though the genre they cover vary, all have one thing in common: each is revolutionizing its field with trailblazing tech – and already reaping the rewards.

The man behind the innovation is CEO and founder, Frank Magliochetti, who has led the business since 2019. Here, we sit down with the CEO as he reveals the surprisingly simple secret to the company’s success, what makes ClickStream’s apps unique, and why the business is such a smart investment option today…

What does a typical day look like for you as the CEO of ClickStream?

It’s about focusing on priorities and not on the noise which creeps into your day. My typical day involves being focused on the initiatives which drive enterprise value, which is critical when dealing with startups like CLIS.

Keeping team members aligned on our quarterly objectives is also vital for our success. Many distractions can enter into your day, so discipline to remain focused on critical success factors is always our daily goal.

What makes ClickStream apps like HeyPal, WinQuick, and Nifter so different from the competition?

Let me walk you through each! HeyPal is different from the competition in one simple way: users learn languages the most natural and human way possible – with other people! Studies show that social interaction is a key component, and arguably the most vital aspect of language learning.

HeyPal makes it easy to find new penpals to learn a language with through direct messaging, a special teacher/student matching algorithm, and a common social feed – all of which can be instantly translated from native to learning language instantly, and vice versa.

All the features of HeyPal are built around creating human connections and practicing new languages in context. While traditional learning methodologies like flashcards, rote memorization, and lessons are important to language learning, many platforms lack social interaction and the “live” components. This is where real practice occurs and why many who study new languages never actually apply those learnings, and often lose their progress.

Beyond the base human interactions, many language learners find that special person and a keen interest, offering more motivation to “impress” their counterparts, and providing the missing, but vital, accountability factor.

Then we have WinQuik. This is one of only two platforms in the market that offers live-hosted trivia games for Android and iOS. Trivia HQ is the other. WinQuik’s live games are different – and better than – HQ because of our unique timing mechanism. Our technology allows users to be timed as they answer live trivia questions. The ones who answer the most questions correctly in the fastest amount of time reach the top of WinQuik’s leaderboard. WinQuik’s payouts are larger because the app can isolate the top fastest users, whereas HQ splits the pot amongst the thousands who got all 10 questions correct that day leading to diluted payouts.

Also, WinQuik has layered security measures to ensure bots, duplicate accounts, and unverified users do not play and do not end up on the leaderboard. Other trivia apps like HQ seem to be more passive on such security efforts.

Plus, unlike HQ, WinQuik offers four different game types that can be played 24/7 including a 1 vs. 1 challenge feature that allows users to play friends and family in trivia contests for coins that they “bet” against each other. Cash prizes are offered for users who complete the most amount of 1 vs. 1 challenge in a week.

Nifter is a unique NFT platform because of its niche appeal to music lovers. It is the first NFT marketplace to focus solely on songs being minted as NFTs. There is no other ‘noise’ on the platform such as dancing cats or artworks of French Bulldogs. Currently, other NFT marketplaces such as Nifty drop NFTs for collectibles that support the artist and their music, but aren’t the actual songs – album art, fan experiences, etc. ClickStream is working to partner with major record labels, music groups, producers, and recording artists to tap into the uncharted territory of song NFTs. Other platforms have shied away from minting the non-independent songs because of an unwillingness to work with the entities that own the music. Nifter’s business model is to partner with the music giants to create a brand extension for their artists.

Are your current apps large enough to sustain the company as a competitive investment in the major public markets?

Absolutely, or we would never have invested in them. The HeyPal segment exceeds 1 billion, and the NFT segment is at an embryonic stage. This segment is going to explode and we have a turnkey marketplace that can go horizontal in any segment. It is a transferable platform. The opportunity is enormous. Then, our children’s entertainment and education app, Joey’s Animal Kingdom, is in a segment that is growing by double digits, with the global segment is in the billions.

How are you capitalizing the company and will it be sustainable on the market? Is the company financing through debt or through equity and how will that affect shareholder value?

We finance our operations and growth through equity. Don’t lose sight: we are an OTC company in a startup situation in which we internally finance start-up projects. In other words, we are an incubator. Financing OTC enterprises is challenging and we have our niche in how we raise capital. To date, it has worked.

It is our intent for the successful companies in our asset portfolio that we will seek additional capital by externally funding them. An example of which could be uplisting one of our subsidiaries. This will provide enormous enterprise value CLIS.

Where do you see the company 5 years from now?

It is our goal to have 3 to 4 subsidiaries listed to Nasdaq and to have CLIS as a Nasdaq listed company.

Why should someone buy stock in your company?

It is our opinion that our stock is grossly undervalued at this time. Our subsidiary values are grossly undervalued. All OTC stocks are speculative for a host of reasons – and Sustainability and Growth Potential are key indicators of unrealized value. Compare the markets our subsidiaries are into the Sustainability and Growth Potential and you will c see we are clearly positioned for success. There is no guarantee, however, there’s no doubt about it that we are in explosive segments.

ABOUT FRANK MAGLIOCHETTI

Frank Magliochetti owes his professional success to his expertise in two areas: medicine and finance. After obtaining a BS in pharmacy from Northeastern University, he stayed on to enroll in the Masters of Toxicology program. He later specialized in corporate finance, receiving an MBA from The Sawyer School of Business at Suffolk University. His educational background includes completion of the Advanced Management Program at Harvard Business School and the General Management Program at Stanford Business School. Frank Magliochetti has held senior positions at Baxter International, Kontron Instruments, Haemonetics Corporation, and Sandoz. Since 2000, he has been a managing partner at Parcae Capital, where he focuses on financial restructuring and interim management services for companies in the healthcare, media, and alternative energy industries. Last year, he was appointed chairman of the board at Grace Health Technology, a company providing an enterprise solution for the laboratory environment.

Frank is the CEO of ClickStream, ClickStream’s business operations are focused on the development and implementation of apps that disrupt such as WinQuik™, a free to play synchronized mobile app and digital gaming platform. The platform is designed to enable WinQuik™ users to have fun, interact and compete against each other in order to win real money and prizes. Twitter at @ClickstreamC  @WinQuikApp, Nifter™, a music NFT marketplace that allows recording artists to create and sell limited edition authenticated NFTs, and their ever expanding foreign language exchange social learning app  @HeyPalApp.

Frank was appointed Chairman and Chief Executive Officer at Designer Genomics International, Inc. The Company has accumulated a growing body of evidence that highlights a link between alterations in the immune and inflammatory systems and the development of chronic human disease. The Company is visionary and has established itself as a leader in the field of inflammatory and immune genetic DNA and RNA biomarkers that play a causative role in debilitating conditions, such as atherosclerosis/heart disease, diabetes, arthritis, inflammatory bowel disease, post-traumatic stress disorders (PTSD) and cancer.
A proprietary state-of-the art data mining bioinformatics program, called ‘cluster analysis’ will be used to measure disease development susceptibility with potential for earlier diagnosis and intervention. The company is developing a healthcare program based on its proprietary genetic panels that will allow people to be their own healthcare advocate and take an active role in their health status as well as longevity.
Frank is a highly sought after multifaceted senior C level executive.

This image has an empty alt attribute; its file name is frankmagliochetti_FrankMagliochettiNews.jpg
Mr. Frank Magliochetti MBA
Managing Partner
Parcae Capital
www.parcaecapitalcorp.com
www.frankmagliochetti.com

Filed Under: App Development, ClickStream, E-Learning, E-Learning, Featured, Gaming Innovations, HeyPal App, Language Apps, Learning Apps, News, NFT's, Nifter, Online Trivia Apps, Trends Tagged With: , , , , , , ,

Early Signs of Disease Identified with Wearable Sensors

January 24, 2017 by

Wearable Sensors May Help Identify Early Signs of Disease

Wearable technologies may be able to do much more than monitor a person’s blood pressure or total number of steps each day, according to a new study, which suggests wearable sensors can detect early signs of serious disease.

Wearable biosensors, otherwise known as wearables, are a low-cost technology capable of measuring physiological parameters continuously or frequently. Biosensor technology is a promising approach to monitoring physiological measurements, and these devices could potentially identify significant changes in health conditions. Capable of passive and routine recording, the technology can provide immediate real-time delivery of multiple measurements to the wearer or physician. Software simplifies the technology, so using wearable biosensors requires minimal training and attention from the wearer or the clinician.frank-magliochetti-biosensors-healthcare-report

In addition to physiological measurements, wearable devices can capture the wearer’s physical activities, such as walking, running, and biking, often in conjunction with a GPS to provide information about the location of the activity.

Wearables can Track Health and Provide Useful Health Information

The newest generation of portable biosensors can measure health-related physiology changes during various activities. The goal of the study, published in PLOS Biology in January 2017, was to investigate the use of portable biosensors in this capacity and their potential role in health management, specifically in the diagnosis and analysis of disease.

The researchers fitted participants with between one and seven commercially available activity monitors. Over the course of the study, the scientists recorded more than 250,000 daily measurements, including participants’ heart rate, skin temperature, blood oxygen, sleep and calories expended collected from up to 43 individuals. The scientists then combined biosensor information with medical measurements to develop a personalized, activity-based normalization framework, which they used to identify abnormal physiological signals and detect disease.

Several participants reported minor cold-like illnesses in the study’s first two years. At the onset of these illnesses, the sensors detected higher than normal readings for skin temperature and heart rate. Blood tests showed an increase in inflammation before symptoms occurred.

Biosensors-frankmagliochetti-reportThe devices could detect physiological differences, namely variations in heart rate patterns, between insulin-sensitive and insulin-resistant individuals. The researchers also found interesting physiological changes associated with alterations in environment. Participants’ blood oxygen levels decreased during high-altitude flight, for example, and this decrease in oxygen levels correlated with fatigue.

The wearables even detected physiological changes in one person – lead author of the study, Michael Snyder – who later turned out to have Lyme disease. The geneticist never developed the telltale bulls-eye rash that usually precedes the condition, but his smart watch and other sensors detected changes in his own oxygen levels and heart rate. Shortly afterwards, Snyder developed symptoms and received an official diagnosis of Lyme disease.

The researchers concluded by saying the portable biosensors can provide information useful for the monitoring of personal activities and physiology. These devices will likely play an important role in health management and access to care by those traditionally limited by geography or socioeconomic class.

Lead author of the study, Michael Snyder, said in a press release that today’s wearables are “the equivalent of oral thermometers but you’re measuring yourself all the time.” He added wearables might someday act as a “check engine” light that tells the wearer when it is time to see a doctor.

Source

http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2001402

http://www.biosciencetechnology.com/news/2017/01/testing-wearable-sensors-check-engine-light-health-0

Frank Magliochetti is Managing Partner for Parcae Capital

  • North Andover, Massachusetts

This column of posts is directed at the Healthcare Industry.  Frank plans to release new sites dedicated to the industry. Frank currently assists companies who are building, restructuring, transforming and resurrecting there business’s. An example of his client base are, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.

Filed Under: Bio/Pharma, Featured, Healthcare Trends, Medicine, News, Trends Tagged With: , , , , , , , ,

Augmented Reality in Healthcare

December 22, 2016 by

Augmented Reality: A Disruptive Trend that is Changing Healthcare

Google Glass and other types of augmented reality (AR) never really took hold in the consumer market but the advanced technology is now poised to be a disruptive trend that will forever change healthcare for patients and providers.frankmagliochettireport_medicalaugmentedreality
A Q4 2016 report by ABI Research suggests augmented reality will gain momentum as medical professionals seek out new tools and technologies to improve care and outcome for their patients. The research firm suggests regulatory activity will push the medical profession towards AR.

About Augmented Reality in Medicine

Augmented reality is a live view of a real-world environment supplemented with computer-generated sounds, graphics or other sensory input. Unlike virtual reality, which entirely replaces the real world with a simulated one, augmented reality replaces only certain elements.
AR can include “see what I see” applications, education and training. “See what I see” apps can transmit what EMTs see to emergency department physicians. In medical applications, augmented reality applications can simulate how it would feel to have certain medical conditions.
frankmagliochetti_augmentedrealityinmedicineAR applications (apps) can help patients check visual symptoms against a medical database or share information in real time with their doctors. Patients with hearing problems can use AR apps and their smart phones to convert auditory information, such as the screech of brakes or a loudspeaker announcement on an airplane, into text displayed on the smart phone. AR apps can highlight maps of wheelchair-friendly routes when an individual visits a city for the first time.
Augmented reality can provide medical training to a large number of students, even those living in remote or impoverished areas. Students use AR to practice surgical techniques, or even allow experienced surgeons to practice procedures on a three-dimensional AR rending of a patient before performing the procedure on the actual patient.

Augmented Reality Applications are Already in Use

Eye Decide by OrcaMD is an educational application that could potential improve patient compliance. This education tool simplifies complex eye conditions and treatments in a way that improves knowledge, understanding and retention. Users can view the eyeball from any angle, with and without skin. Eye Decide also demonstrates the effects of cataracts, age-related macular degeneration (AMD), and other eye conditions, so that patients can see what a particular disease will eventually do to their vision without proper treatment.
AccuVein displays a map of a patient’s vein to make placing needles easier and more accurate. The healthcare practitioner uses a handheld scanner that detects heat radiating from the veins, converts information gathered about that heat into a map of the veins, and then projects this map onto the patient’s skin. AccuVein enjoys a 40 percent annual growth rate. By the middle of 2015, this augmented reality app had already helped more frankmagliochetti_report-augment-reality-healthcarethan 10 million patients. Sales will likely continue at a robust pace as patients and nurses demand the technology to reduce the average number of “sticks” involved in placing an intravenous (IV) needle.
Many legally blind people still have some vision but cannot see well enough to recognize faces, drive, read, or avoid obstacles in their path. VA-ST is a visor that combines a 3D camera with a computer to enhance vision by improving contrast, and highlighting edges and features. Users can even pause or zoom video for a clearer view. This technology will become more popular as the population of the United States ages and suffers age-related vision loss.
Like other industries, medicine leverages new technology to improve efficiencies and performance. The move from a per-service reimbursement structure towards one that focuses on quality of care will spur growth of augmented reality in medical settings.

Source
https://www.abiresearch.com/market-research/product/1025909-ar-in-telemedicine-training-and-first-resp/
https://itunes.apple.com/us/app/eye-decide-education-engagement/id454280553?mt=8
https://orcahealth.com/
http://www.accuvein.com/inf/
http://www.accuvein.com/2015/06/vein-visualization-emerges-as-premier-augmented-reality-application/
http://www.va-st.com/smart-specs/

Frank Magliochetti is Managing Partner for Parcae Capital.

  • North Andover, Massachusetts

This column of posts is directed at the Healthcare Industry.  Frank plans to release new sites dedicated to the industry.  He currently assists companies who are building, restructuring, transforming and resurrecting there business’s. An example of his client base are, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.

frankmagliochetti_ParcaeCapital

Filed Under: Augmented Reality, Bio/Pharma, Featured, Healthcare Trends, Medicine, News Tagged With: , , , ,

Wearable Medical Devices: Smart Tech

December 1, 2016 by

Smart Tech:  Wearable Medical Devices 2017 – 2020

Smart technologies will continue to drive the ever-growing medical wearable device market in 2017 and well into the future.
The global medical wearable devices market topped $3.2 billion in revenue in 2015, according to Mordor Intelligence, which expects the market to surpass $7.9 billion in 2020 as the industry continues to grow at a healthy CAGR of 19.8 percent during that period.
wearablemedicaldevices_frank-magliochetti-reportWearable medical devices, known simply as “wearables,” are small pieces of equipment featuring sensors that attach to the body. These sensors detect and monitor changes in specific body signatures produced by various body systems and organs. Early wearable technology allowed consumers to monitor vital signs. Today’s wearables allow users to monitor food intake, activity, and sleep levels. Tomorrow’s devices may provide continuous monitoring of glucose levels, smart clothing for infants, and smart EKG necklaces for those with heart problems.
Wearables have the potential to fill a number of applications in remote patient monitoring, sports and fitness monitoring, and home healthcare. Simplified usage of these devices, coupled with the ability to synchronize with smartphones and tables, assisted growth in this segment.
Global Wearable Devices Market- Market Dynamics

There are immense potential socio-economics of wearable medical devices for multiple sectors. Fitness devices that encourage the users to exercise can significantly reduce healthcare costs, for example.

Investors are focusing on a wide variety of projects, ranging from downloadable apps to improving the size, cost and sensitivity of sensors.wearablemedicaldevices_frankmagliochettireport

Several factors propel the growth of the global wearable market. Technological innovation is perhaps the most important factor, as these advancements lead to the introduction of new products.
Diabetes and other chronic diseases are rising at a seemingly uncontrollable rate. Wearable devices will play an increasingly important role in helping doctors and patients manage chronic diseases.

Developers make wearable devices easier to use and simplify interpretation of the data collected. Simplicity encourages use.
Market penetration of smartphones, smart watches and other wearable devices will promote the use of wearable medical technology. These devices have already penetrated the market deeply, with the worldwide smart watch shipments reaching about 25 million in 2015.

Some factors, such as reimbursement issues and high device cost, will restrain the medical wearables market somewhat but the effect should be minimal, as demand should remain high.
Several companies are already exploiting the growing interest in medical wearable technology by creating affordable products that offer high value to users and their healthcare partners.

Some of the key players already operating in the medical wearable device market include:
• Dräger
• Fitbit Inc.
• Intelesens Ltd.
• Lifewatch AG
• Omron Corporation
• Polar Electro
• Philips Electronics
• Withings SAS
These wearable manufacturers will likely improve hardware in existing products and create sturdier devices within the next few years. Hardware and device ifrankmagliochettireport_wearable-medical-devicesnnovations may include larger and easier to read displays, extended battery life, waterproof hardware, and compatibility with GPS and other sensors included in a standard smart phone. Software innovations may include advanced monitoring systems and improved patient care software, such as breathing exercises and on-demand nutrition counseling.
The wearable market is expanding because the devices are autonomous, which makes them easy to use, and non-invasive. It is also growing because of its ability to help prevent and manage chronic diseases.

Source
https://www.mordorintelligence.com/industry-reports/global-wearable-medical-device-market-industry

Frank Magliochetti is Managing Partner for Parcae Capital.

  • North Andover, Massachusetts

This column of posts is directed at the Healthcare Industry.  Frank plans to release a new site dedicated to the industry.  He currently assists companies who are building, restructuring, transforming and resurrecting there business’s. An example of his client base are, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.

frankmagliochetti_ParcaeCapital

Filed Under: Featured, News Tagged With: , , , , ,

CDC Warns Against Nasal Spray Vaccine

November 7, 2016 by

CDC: Don’t Not Using Nasal Flu Vaccine for 2016/2017 Season

Frank Magliochetti Report

The Centers for Disease Control and Prevention (CDC) has issued its 2016-2017 influenza vaccination recommendations, which includes the use of inactivated influenza vaccine (IIV) and the recombinant influenza vaccine (RIV). One of the most notable changes to the yearly recommendations is that the CDC is not recommending the use of nasal spray flu vaccinations using live attenuated frankmagliochetti-report_flu-shot-vaccineinfluenza vaccine (LAIV) during 2016-2017, as studies show it is not effective against preventing the flu.
The studies show LAIV had no protective benefit from children ages 2 to 17. In contrast, children who received an injection were 63 percent less likely to catch influenza than are those who received no vaccination at all.
While researchers have not yet determined the underlying cause of the loss of efficacy, but it could be due to changes in the dominant viral strains circulating in the nation during flu season. LAIV worked just as well as the shot at protecting children from H3N3 and the influenza B strain in recent flu seasons, according to a study published in the journal Pediatrics, but youngsters who received LAIV were three times more likely to suffer infection with H1N1 than were children who got the shot.
H1N1 has been the dominant strain for the past few years, according to a February 2016 CDC report, which means LAIVs can leave patients unprotected from the strains most likely to cause illness this flu season.

About Vaccinations, LAIVs, and Flu Season

Influenza vaccinations protect millions of people in the United States from developing influenza each year. Flu shots also reduce severity of influenza symptoms when it does develop, and prevents cdc-frankmagliochettireporthospitalizations relating to the flu. CDC recommends yearly flu shots for everyone 6 months and older. Antibodies typically take about two weeks to develop.
Many patients, and parents of pediatric patients, prefer LAIVs because of the perceived pain or trauma of an injection. LAIVs have been under development in the United States since the 1960s, according to the CDC, and the intranasal, trivalent, cold-adapted, live, LAIV received approval in 2003 as an option for among health patients aged 5 to 49 years. Because the nasal spray contains live, weakened influenza viruses, LAIV theoretically stimulates a stronger immune response than the shots, which contain killed viruses.
Influenza activity often begins to increase in October and peak sometime in late winter or early spring. The peak week of flu activity for the 2015-2016 season occurred on the last week of March 2016,

according to the CDC, which was one of the later season peaks on record. The CDC’s adjusted overall vaccine effectiveness (VE) against influenza A and B viruses for all ages was 47 percent, while the overall VE against A(H1N1)pdm09 was 41 percent and the overall VE against influenza B was 55 percent.

Vaccine manufacturers will provide an estimated 157 to 168 million doses of injectable influenza vaccine for the U.S. market. This is on par with last year’s vaccine distribution.

Source
https://www.cdc.gov/mmwr/volumes/65/rr/rr6505a1.htm?s_cid=rr6505a1_w

http://pediatrics.aappublications.org/content/early/2016/01/04/peds.2015-3279?sso=1&sso_redirect_count=1&nfstatus=401&nftoken=00000000-0000-0000-0000000000000000&nfstatusdescription=ERROR%3a+No+local+token

https://emergency.cdc.gov/han/han00387.asp

https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5213a1.htm

http://www.cdc.gov/flu/about/season/flu-season-2015-2016.htm

https://www.cdc.gov/flu/professionals/vaccination/vaccinesupply.htm

Frank Magliochetti is Managing Partner for Parcae Capital.

  • North Andover, Massachusetts

This column of posts is directed at the Healthcare Industry.  Frank plans to release a new site dedicated to the industry.  He currently assists companies who are building, restructuring, transforming and resurrecting there business’s. An example of his client base are, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.

frankmagliochetti_ParcaeCapital

Filed Under: Featured, Medicine, News Tagged With: , , ,